P
LLY icon

&Partners’s Eli Lilly LLY Stock Holding History

&Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217M Buy
180,745
+9,049
+5% +$9.25M 0.89% 16
2026
Q1 		$158M Buy
171,696
+11,110
+7% +$11.3M 0.78% 19
2025
Q4 		$173M Buy
160,586
+37,368
+30% +$35.7M 0.9% 15
2025
Q3 		$94M Buy
123,218
+3,918
+3% +$2.92M 0.6% 22
2025
Q2 		$93.1M Buy
119,300
+26,762
+29% +$20.8M 0.71% 19
2025
Q1 		$76.2M Buy
92,538
+25,466
+38% +$21.2M 0.81% 16
2024
Q4 		$52.7M Buy
67,072
+27,755
+71% +$23M 0.63% 24
2024
Q3 		$34.8M Buy
39,317
+22,632
+136% +$20.3M 0.67% 16
2024
Q2 		$15.1M Buy
16,685
+14,305
+601% +$11.4M 0.66% 22
2024
Q1 		$1.86M Sell
2,380
-2,602
-52% -$1.85M 0.26% 78
2023
Q4 		$2.92M Buy
4,982
+3,944
+380% +$2.3M 0.71% 29
2023
Q3 		$558K Buy
1,038
+227
+28% +$117K 0.26% 74
2023
Q2 		$380K Buy
811
+135
+20% +$56.6K 0.17% 106
2023
Q1 		$232K Buy
676
+3
+0.4% +$1.01K 0.11% 145
2022
Q4 		$246K Sell
673
-318
-32% -$113K 0.12% 144
2022
Q3 		$320K Buy
991
+90
+10% +$28.5K 0.19% 112
2022
Q2 		$292K Buy
+901
New +$270K 0.17% 123

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

&Partners's LLY Position: Q2 2026 in Review

&Partners increased its Eli Lilly (LLY) stake by 5.3% in Q2 2026, buying an estimated $9.25M and bringing the position to 180,745 shares worth $217M. The position accounts for 0.89% of the portfolio, ranked #16.

&Partners first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 4,641 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • &Partners held 180,745 shares of Eli Lilly worth $217M as of Q2 2026.
  • &Partners bought 9,049 Eli Lilly shares in Q2 2026, an estimated $9.25M.
  • Eli Lilly made up 0.89% of &Partners's portfolio in Q2 2026, its #16 holding.
  • &Partners first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
  • 4,641 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.